Overview

Iloprost Therapy in Patients With Critical Limb Ischemia

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Monitoring efficacy and safety aspects of iv. iloprost therapy of patients with critical limb ischemia by recording clinical parameters.
Details
Lead Sponsor:
Bayer
Treatments:
Iloprost